Zacks Research Expects Weaker Earnings for Core Laboratories

Core Laboratories Inc. (NYSE:CLBFree Report) – Stock analysts at Zacks Research reduced their Q3 2027 EPS estimates for Core Laboratories in a research note issued on Thursday, April 23rd. Zacks Research analyst Team now forecasts that the oil and gas company will earn $0.27 per share for the quarter, down from their prior forecast of $0.32. The consensus estimate for Core Laboratories’ current full-year earnings is $0.57 per share. Zacks Research also issued estimates for Core Laboratories’ FY2027 earnings at $1.06 EPS.

Separately, Weiss Ratings reiterated a “hold (c)” rating on shares of Core Laboratories in a research note on Friday, March 27th. Four equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Core Laboratories currently has an average rating of “Hold” and an average price target of $12.50.

Read Our Latest Report on Core Laboratories

Core Laboratories Stock Up 2.4%

Shares of NYSE:CLB opened at $17.46 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 2.02 and a quick ratio of 1.51. The firm has a market capitalization of $804.03 million, a PE ratio of 26.06, a price-to-earnings-growth ratio of 3.21 and a beta of 1.15. The firm’s 50-day moving average is $16.83 and its two-hundred day moving average is $16.54. Core Laboratories has a 1 year low of $9.72 and a 1 year high of $20.36.

Core Laboratories (NYSE:CLBGet Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.20 by $0.01. The company had revenue of $138.26 million for the quarter, compared to analyst estimates of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.18%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS.

Core Laboratories Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, March 9th. Investors of record on Monday, February 16th were paid a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date was Friday, February 13th. Core Laboratories’s dividend payout ratio is presently 5.97%.

Institutional Trading of Core Laboratories

A number of large investors have recently made changes to their positions in CLB. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Core Laboratories by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after buying an additional 1,170 shares during the period. American Century Companies Inc. increased its stake in shares of Core Laboratories by 14.3% during the second quarter. American Century Companies Inc. now owns 133,033 shares of the oil and gas company’s stock worth $1,533,000 after buying an additional 16,677 shares during the period. Quantbot Technologies LP increased its stake in shares of Core Laboratories by 343.7% during the second quarter. Quantbot Technologies LP now owns 17,520 shares of the oil and gas company’s stock worth $202,000 after buying an additional 13,571 shares during the period. Sei Investments Co. purchased a new stake in shares of Core Laboratories during the second quarter worth approximately $231,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Core Laboratories by 6.2% during the second quarter. The Manufacturers Life Insurance Company now owns 17,932 shares of the oil and gas company’s stock worth $207,000 after buying an additional 1,040 shares during the period. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

About Core Laboratories

(Get Free Report)

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.

Featured Stories

Earnings History and Estimates for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.